Is axillary lymph node clearance required in node-positive breast cancer?

被引:0
|
作者
Nigel J. Bundred
Nicola L. P. Barnes
Emiel Rutgers
Mila Donker
机构
[1] University Hospital of South Manchester,Department of Academic Surgery
[2] Netherlands Cancer Institute,Department of Surgery
[3] Netherlands Cancer Institute,Department of Radiotherapy
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Axillary micrometastases require no further axillary treatment after SNB for patients with early stage breast cancerAfter positive sentinel node biopsy, axillary irradiation provides equivalent regional control to nodal clearance in early breast cancerLess morbidity (especially lymphoedema) is seen after axillary radiotherapyAxillary dissection can be safely omitted in patients with more than two positive sentinel nodes after breast-conserving surgery, provided whole-breast radiation therapy is planned
引用
收藏
页码:55 / 61
页数:6
相关论文
共 50 条
  • [21] The prognostic impact of the axillary lymph node ratio in patients with micrometastatic node-positive breast cancer.
    Truong, PT
    Cserni, G
    Woodward, W
    Janni, W
    Tai, P
    Vlastos, G
    Vinh-Hung, V
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S126 - S127
  • [22] Identification of Risk Factors Associated with Axillary Lymph Node Metastasis for Sentinel Lymph Node-Positive Breast Cancer Patients
    He, Zhen
    Lan, Xiaowen
    Tan, Yuting
    Lin, Xiao
    Wen, Ge
    Wang, Xicheng
    Huang, Xiaobo
    Yang, Fan
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [23] Outcomes of sentinel lymph node-positive breast cancer patients after mastectomy with or without axillary lymph node dissection
    Matsumoto, A.
    Umemoto, Y.
    Yoshikawa, M.
    Jinno, H.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S71 - S72
  • [24] The lymph node ratio as prognostic factor in node-positive breast cancer
    Voordeckers, M
    Vinh-Hung, V
    Van de Steene, J
    Lamote, J
    Storme, G
    RADIOTHERAPY AND ONCOLOGY, 2004, 70 (03) : 225 - 230
  • [25] Lymph node ratio as prognostic factor in node-positive breast cancer
    Storme, G.
    Nieto, Y.
    Vinh-Hung, V.
    Hortobagyi, G.
    EJC SUPPLEMENTS, 2005, 3 (02): : 76 - 77
  • [26] Prognostic Value of Lymph Node Ratio in Node-positive Breast Cancer
    Dings, P. J.
    Francissen, C. M.
    Elferink, M. A.
    Strobbe, L. J.
    Van Laarhoven, H. W.
    De Wilt, J. H.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S62 - S62
  • [27] The lymph node ratio as prognostic factor in node-positive breast cancer
    Voordeckers, M
    Vinh-Hung, V
    Van de Steene, J
    Lamote, J
    Storme, G
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S243 - S244
  • [28] Sentinel lymph node biopsy and axillary marking after neoadjuvant treatment in node-positive breast cancer patients
    Guardia Jimena, P.
    Santos Bueno, A.
    Rebollo Aguirre, A.
    Sanchez de Mora, E.
    Jimenez Heffernan, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S591 - S592
  • [29] Validity of omission of axillary lymph node dissection after neoadjuvant chemotherapy for node-positive primary breast cancer
    Matsumoto, Akiko
    Umemoto, Yasuko
    Tsukahara, Daisuke
    Jinno, Hiromitsu
    CANCER RESEARCH, 2020, 80 (04)
  • [30] Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer
    Moore, Alexandra M.
    Caudle, Abigail S.
    Sun, Susie X.
    Yi, Min
    Smith, Benjamin D.
    Valero, Vicente
    Yang, Wei
    Kuerer, Henry M.
    Hunt, Kelly K.
    Teshome, Mediget
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (01) : 84 - 91